abstract |
The present invention relates to a novel phenyltriazole derivative, pharmaceutical compositions containing this compound, and methods of treatment together with these. The compound of the invention is in particular considered useful for the treatment of diseases and disorders of the central nervous system which are sensitive to the modulation of GABAA receptors containing the a5 subunit. |